135 related articles for article (PubMed ID: 33393648)
1. Study of inflammatory biomarkers in COPD and asthma exacerbations.
Vassiliou AG; Vitsas V; Kardara M; Keskinidou C; Michalopoulou P; Rovina N; Dimopoulou I; Orfanos SE; Tsoukalas G; Koutsoukou A; Kotanidou A
Adv Respir Med; 2020; 88(6):558-566. PubMed ID: 33393648
[TBL] [Abstract][Full Text] [Related]
2. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers.
Krommidas G; Kostikas K; Papatheodorou G; Koutsokera A; Gourgoulianis KI; Roussos C; Koulouris NG; Loukides S
Respir Med; 2010 Jan; 104(1):40-6. PubMed ID: 19782551
[TBL] [Abstract][Full Text] [Related]
3. Leptin and TNF-alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters.
Calikoglu M; Sahin G; Unlu A; Ozturk C; Tamer L; Ercan B; Kanik A; Atik U
Respiration; 2004; 71(1):45-50. PubMed ID: 14872110
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated adipokine metabolism in chronic obstructive pulmonary disease.
Breyer MK; Rutten EP; Locantore NW; Watkins ML; Miller BE; Wouters EF;
Eur J Clin Invest; 2012 Sep; 42(9):983-91. PubMed ID: 22703238
[TBL] [Abstract][Full Text] [Related]
5. Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease.
Kleniewska A; Walusiak-Skorupa J; Piotrowski W; Nowakowska-Świrta E; Wiszniewska M
J Occup Health; 2016 Jul; 58(4):333-9. PubMed ID: 27265531
[TBL] [Abstract][Full Text] [Related]
6. Airway IL-1β and Systemic Inflammation as Predictors of Future Exacerbation Risk in Asthma and COPD.
Fu JJ; McDonald VM; Baines KJ; Gibson PG
Chest; 2015 Sep; 148(3):618-629. PubMed ID: 25950204
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.
Karadag F; Karul AB; Cildag O; Yilmaz M; Ozcan H
Lung; 2008; 186(6):403-9. PubMed ID: 18807087
[TBL] [Abstract][Full Text] [Related]
9. Assessment of leptin and resistin levels in patients with chronic obstructive pulmonary disease.
Kumor-Kisielewska A; Kierszniewska-Stępień D; Pietras T; Kroczyńska-Bednarek J; Kurmanowska Z; Antczak A; Górski P
Pol Arch Med Wewn; 2013; 123(5):215-20. PubMed ID: 23611920
[TBL] [Abstract][Full Text] [Related]
10. [Systemic inflammation in patients with chronic obstructive pulmonary disease and obesity].
Ovsyannikov ES; Avdeev SN; Budnevsky AV
Ter Arkh; 2020 Apr; 92(3):13-18. PubMed ID: 32598787
[TBL] [Abstract][Full Text] [Related]
11. Leptin, resistin and fetuin a concentration as the potential useful biomarkers in stable COPD - An exploratory study.
Małujło-Balcerska E; Kumor-Kisielewska A; Śmigielski W
Cytokine; 2023 Sep; 169():156275. PubMed ID: 37354646
[TBL] [Abstract][Full Text] [Related]
12. Gender differences in the adipose secretome system in chronic obstructive pulmonary disease (COPD): a pivotal role of leptin.
Breyer MK; Rutten EP; Vernooy JH; Spruit MA; Dentener MA; van der Kallen C; vanGreevenbroek MM; Wouters EF
Respir Med; 2011 Jul; 105(7):1046-53. PubMed ID: 21367591
[TBL] [Abstract][Full Text] [Related]
13. Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles.
Ghebre MA; Pang PH; Diver S; Desai D; Bafadhel M; Haldar K; Kebadze T; Cohen S; Newbold P; Rapley L; Woods J; Rugman P; Pavord ID; Johnston SL; Barer M; May RD; Brightling CE
J Allergy Clin Immunol; 2018 Jun; 141(6):2027-2036.e12. PubMed ID: 29709671
[TBL] [Abstract][Full Text] [Related]
14. Correlation between hyperinflation defined as an elevated RV/TLC ratio and body composition and cytokine profile in patients with chronic obstructive pulmonary disease.
Rubinsztajn R; Przybyłowski T; Maskey-Warzęchowska M; Paplińska-Goryca M; Karwat K; Nejman-Gryz P; Chazan R
Pneumonol Alergol Pol; 2015; 83(2):120-5. PubMed ID: 25754053
[TBL] [Abstract][Full Text] [Related]
15. Leptin as local inflammatory marker in COPD.
Broekhuizen R; Vernooy JH; Schols AM; Dentener MA; Wouters EF
Respir Med; 2005 Jan; 99(1):70-4. PubMed ID: 15672852
[TBL] [Abstract][Full Text] [Related]
16. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.
Lacoma A; Prat C; Andreo F; Lores L; Ruiz-Manzano J; Ausina V; Domínguez J
Int J Chron Obstruct Pulmon Dis; 2011; 6():157-69. PubMed ID: 21468168
[TBL] [Abstract][Full Text] [Related]
17. Associations between BODE index and systemic inflammatory biomarkers in COPD.
Gaki E; Kontogianni K; Papaioannou AI; Bakakos P; Gourgoulianis KI; Kostikas K; Alchanatis M; Papiris S; Loukides S
COPD; 2011 Dec; 8(6):408-13. PubMed ID: 22149400
[TBL] [Abstract][Full Text] [Related]
18. Plasma leptin and insulin-like growth factor I levels during acute exacerbations of chronic obstructive pulmonary disease.
Kythreotis P; Kokkini A; Avgeropoulou S; Hadjioannou A; Anastasakou E; Rasidakis A; Bakakos P
BMC Pulm Med; 2009 Apr; 9():11. PubMed ID: 19344528
[TBL] [Abstract][Full Text] [Related]
19. Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS.
Garudadri S; Woodruff PG; Han MK; Curtis JL; Barr RG; Bleecker ER; Bowler RP; Comellas A; Cooper CB; Criner G; Dransfield MT; Hansel NN; Paine R; Krishnan JA; Peters SP; Hastie AT; Martinez FJ; O'Neal WK; Couper DJ; Alexis NE; Christenson SA
Chest; 2019 May; 155(5):908-917. PubMed ID: 30684474
[TBL] [Abstract][Full Text] [Related]
20. The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year.
Kolsum U; Roy K; Starkey C; Borrill Z; Truman N; Vestbo J; Singh D
Int J Chron Obstruct Pulmon Dis; 2009; 4():149-56. PubMed ID: 19436686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
